These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 39068575)
1. The Association of pri-miR34 b/c Gene Polymorphism and Clinicopathologic Data in Breast Cancer Patients. Kongton T; Sanguansin S; Saelee P; Thongmee A; Pongstaporn W Asian Pac J Cancer Prev; 2024 Jul; 25(7):2415-2420. PubMed ID: 39068575 [TBL] [Abstract][Full Text] [Related]
2. Pri-miR-34b/c rs4938723 Polymorphism Contributes to Coronary Artery Disease Susceptibility. Cen J; Xiong Q; Yang X; Guo J; Xiong XD; Zhang A Arch Med Res; 2019 May; 50(4):170-174. PubMed ID: 31499476 [TBL] [Abstract][Full Text] [Related]
3. Pri-miR-34b/c rs4938723 polymorphism increased the risk of prostate cancer. Hashemi M; Danesh H; Bizhani F; Narouie B; Sotoudeh M; Nouralizadeh A; Sharifiaghdas F; Bahari G; Taheri M Cancer Biomark; 2017; 18(2):155-159. PubMed ID: 27983526 [TBL] [Abstract][Full Text] [Related]
4. Combined analysis of pri-miR-34b/c rs4938723 and TP53 Arg72Pro with cervical cancer risk. Yuan F; Sun R; Chen P; Liang Y; Ni S; Quan Y; Huang J; Zhang L; Gao L Tumour Biol; 2016 May; 37(5):6267-73. PubMed ID: 26619844 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of the pri-miR-34b/c rs4938723 polymorphism and its association with breast cancer risk. Sanaei S; Hashemi M; Rezaei M; Hashemi SM; Bahari G; Ghavami S Biomed Rep; 2016 Jul; 5(1):125-129. PubMed ID: 27347415 [TBL] [Abstract][Full Text] [Related]
6. Pri-miR-34b/c rs4938723 polymorphism is associated with a decreased risk of gastric cancer. Pan XM; Sun RF; Li ZH; Guo XM; Qin HJ; Gao LB Genet Test Mol Biomarkers; 2015 Apr; 19(4):198-202. PubMed ID: 25658980 [TBL] [Abstract][Full Text] [Related]
7. Pri-miR-34b/c rs4938723 polymorphism is associated with the risk of childhood acute lymphoblastic leukemia. Hashemi M; Bahari G; Naderi M; Sadeghi-Bojd S; Taheri M Cancer Genet; 2016 Nov; 209(11):493-496. PubMed ID: 27886674 [TBL] [Abstract][Full Text] [Related]
8. Interactions of miR-34b/c and TP-53 polymorphisms on the risk of nasopharyngeal carcinoma. Li L; Wu J; Sima X; Bai P; Deng W; Deng X; Zhang L; Gao L Tumour Biol; 2013 Jun; 34(3):1919-23. PubMed ID: 23504554 [TBL] [Abstract][Full Text] [Related]
9. The association of miR34b/c and TP53 gene polymorphisms with Wilms tumor risk in Chinese children. Wang J; Lou S; Huang X; Mo Y; Wang Z; Zhu J; Tian X; Shi J; Zhou H; He J; Ruan J Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32083300 [TBL] [Abstract][Full Text] [Related]
10. Association between polymorphisms in the promoter region of pri-miR-34b/c and risk of hepatocellular carcinoma. Chen LL; Shen Y; Zhang JB; Wang S; Jiang T; Zheng MQ; Zheng ZJ; Chen CX Genet Mol Res; 2016 Oct; 15(4):. PubMed ID: 27808368 [TBL] [Abstract][Full Text] [Related]
11. Single-nucleotide polymorphism of the pri-miR-34b/c gene is not associated with susceptibility to congenital heart disease in the Han Chinese population. Liu YM; Wang Y; Peng W; Wu Z; Wang XH; Wang ML; Wang W; Sun J; Zhang ZD; Mo XM Genet Mol Res; 2013 Aug; 12(3):2937-44. PubMed ID: 24065649 [TBL] [Abstract][Full Text] [Related]
12. Association of TP53 rs1042522 C>G and miR-34b/c rs4938723 T>C polymorphisms with hepatoblastoma susceptibility: A seven-center case-control study. Liu P; Zhuo ZJ; Zhu J; Yang Z; Xin Y; Li S; Li L; Li Y; Wang H; He J J Gene Med; 2020 Jul; 22(7):e3182. PubMed ID: 32166848 [TBL] [Abstract][Full Text] [Related]
13. The genetic association between pri-miR-34b/c polymorphism (rs4938723 T > C) and susceptibility to cancers: evidence from published studies. Li X; Wang L; Yu J; Xu J; Du J Tumour Biol; 2014 Dec; 35(12):12525-34. PubMed ID: 25190019 [TBL] [Abstract][Full Text] [Related]
14. Pri-miR-124 rs531564 and pri-miR-34b/c rs4938723 polymorphisms are associated with decreased risk of esophageal squamous cell carcinoma in Chinese populations. Zhang J; Huang X; Xiao J; Yang Y; Zhou Y; Wang X; Liu Q; Yang J; Wang M; Qiu L; Zheng Y; Zhang P; Li J; Wang Y; Wei Q; Jin L; Wang J; Wang M PLoS One; 2014; 9(6):e100055. PubMed ID: 24945256 [TBL] [Abstract][Full Text] [Related]
15. Associations of pri-miR-34b/c and pre-miR-196a2 polymorphisms and their multiplicative interactions with hepatitis B virus mutations with hepatocellular carcinoma risk. Han Y; Pu R; Han X; Zhao J; Zhang Y; Zhang Q; Yin J; Xie J; Shen Q; Deng Y; Ding Y; Li W; Li J; Zhang H; Cao G PLoS One; 2013; 8(3):e58564. PubMed ID: 23516510 [TBL] [Abstract][Full Text] [Related]
16. Pri-Mir-34b/C and Tp-53 Polymorphisms are Associated With The Susceptibility of Papillary Thyroid Carcinoma: A Case-Control Study. Chen P; Sun R; Pu Y; Bai P; Yuan F; Liang Y; Zhou B; Wang Y; Sun Y; Zhu J; Zhang L; Gao L Medicine (Baltimore); 2015 Sep; 94(38):e1536. PubMed ID: 26402809 [TBL] [Abstract][Full Text] [Related]
17. pri-miR-34b/c rs4938723 polymorphism is associated with hepatocellular carcinoma risk: a case-control study in a Chinese population. Liu CJ; Ma XW; Zhang XJ; Shen SQ Int J Mol Epidemiol Genet; 2017; 8(1):1-7. PubMed ID: 28337312 [TBL] [Abstract][Full Text] [Related]
18. Pri-miR-34b/c rs4938723 polymorphism contributes to acute lymphoblastic leukemia susceptibility in Chinese children. Tong N; Chu H; Wang M; Xue Y; Du M; Lu L; Zhang H; Wang F; Fang Y; Li J; Wu D; Zhang Z; Sheng X Leuk Lymphoma; 2016; 57(6):1436-41. PubMed ID: 26380954 [TBL] [Abstract][Full Text] [Related]
19. Association between miR34b/c polymorphism rs4938723 and cancer risk: a meta-analysis of 11 studies including 6169 cases and 6337 controls. Wang X; Lu X; Fang Y; Chen H; Deng X; Peng C; Li H; Shen B Med Sci Monit; 2014 Oct; 20():1977-82. PubMed ID: 25326793 [TBL] [Abstract][Full Text] [Related]
20. Polymorphisms of the pri-miR-34b/c promoter and TP53 codon 72 are associated with risk of colorectal cancer. Oh J; Kim JW; Lee BE; Jang MJ; Chong SY; Park PW; Hwang SG; Oh D; Kim NK Oncol Rep; 2014 Feb; 31(2):995-1002. PubMed ID: 24337371 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]